New discovery may point to clues about how head and neck cancers spread
WashU Medicine faculty and research members of Siteman Cancer Center have identified a previously unknown population of aggressive tumor cells in difficult-to-treat head and neck cancers.
Prize supports hunt for broad-spectrum antivirals
WashU Medicine infectious diseases expert Michael Diamond, MD, PhD, has won a $2.5 million prize to advance the development of drugs to treat debilitating chikungunya and related viruses.
WashU Medicine names new chair of pediatrics
A nationally recognized pediatric endocrinologist, Madhusmita Misra, MD, pioneered research on bone density and metabolic disorders in young women. Her appointment begins Jan. 4.
$11 million grant to investigate why resident microbes go rogue
WashU Medicine researchers have been awarded a nearly $11 million grant from the National Institutes of Health (NIH) to decode how gut bacteria turn hostile, leading to dangerous infections.
Osteoarthritis therapy study advances with $17 million from ARPA-H
The funding will support a WashU Medicine collaboration with CRISPR Therapeutics and SynGenix, a WashU startup, to move a single-injection treatment to reverse joint damage into clinical trials.
Vaccinating moms protects offspring from deadly superbug
A study in mice by WashU Medicine researchers advances efforts to shield infants from Klebsiella pneumoniae, a dangerous bacterium that causes severe bloodstream infections and is the leading killer of children globally.
Kubanek receives One Mind Rising Star Award
WashU Medicine psychiatry researcher Jan Kubanek was recognized with the One Mind Rising Star Award for his work on applying ultrasound to map and modulate brain circuits involved in depression.
Psilocybin providers follow safety guidelines, study finds
A “mystery shopper” study by WashU researchers found that licensed psilocybin centers in Oregon — the first U.S. state to legalize regulated, supervised use of the psychedelic drug — consistently followed recommended client-screening practices. But the cost of treatment may keep it out of reach for many.
New research shows promise for treating hepatitis C in pregnancy
A study led by Laura Marks, MD, and Madeline McCrary, MD, of WashU Medicine, shows that an oral antiviral regimen can be used safely and effectively in pregnant patients with hepatitis C virus.
Immune cell map uncovers how individual aging trajectories diverge
WashU Medicine researchers have discovered that the ratio between two types of white blood cells can predict whether a person stays healthy as they age or faces an increased risk of disease.
View More Stories